Publication Name	World Journal of Meta-Analysis
Manuscript ID	11829
Country	China

Received	2014-06-07 14:49
Peer-Review Started	2014-06-08 18:40
To Make the First Decision	2014-06-18 18:36
Return for Revision	2014-06-19 11:40
Revised	2014-06-24 19:41
Second Decision	2014-09-10 13:43
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-09-10 14:05
Articles in Press	2014-09-10 14:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-11-20 09:09
Publish the Manuscript Online	2014-12-02 12:25

ISSN	2308-3840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Meta-Analysis
Article Title	Systematic review and meta-analysis of Statins-Fibrates therapy in diabetic dyslipidemia patients
Manuscript Source	Invited Manuscript
All Author List	Shuang Zheng, Yang-Xue Li, Ting-Ting Han, Yao Zhang, Dong-Dong Jiang and Yao-Min Hu
Funding Agency and Grant Number	Funding Agency Grant Number National Scientific Foundation of China 81270946 National Scientific Foundation of China 81170758 National Scientific Foundation of China 30670988
Corresponding Author	Yao-Min Hu, PhD, Department of Endocrinology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, NO.160 Pujian Road, Shanghai 200127, China. amin1031@hotmail.com
Key Words	Statin; Fibrate; Dyslipidemia; Type 2 diabetes; Combination therapy
Core Tip	Both dyslipidemia and type 2 diabetes were established risk factors of cardiovascular diseases. Statins therapy was highly effective at lowering low density lipoprotein cholesterol (LDL-C). However, despite the increasing use of statins as monotherapy for LDL-C reduction, a significant residual cardiovascular risk was still presented in patients with diabetic dyslipidemia. At the same time, Fenofibrate failed to alter the primary clinical endpoints significantly. How about the efficacy of statins-fibrates combination therapy in patients with diabetic dyslipidemia? The results of this meta-analysis showed the combination therapy was more effective on lipid modification and well tolerated but there was no significant effect on preventing cardiovascular diseases.
Publish Date	2014-12-02 12:25
Citation	Zheng S, Li YX, Han TT, Zhang Y, Jiang DD, Hu YM. Systematic review and meta-analysis of Statins-Fibrates therapy in diabetic dyslipidemia patients. World J Meta-Anal 2014; 2(4): 194-203
URL	http://www.wjgnet.com/2308-3840/full/v2/i4/194.htm
DOI	http://dx.doi.org/10.13105/wjma.v2.i4.194

Full Article (PDF)	WJMA-2-194.pdf
Full Article (Word)	WJMA-2-194.doc
Manuscript File	11829-Review.doc
Answering Reviewers	11829-Answering reviewers.pdf
Copyright License Agreement	11829-Copyright assignment.pdf
Peer-review Report	11829-Peer review(s).pdf
Scientific Misconduct Check	11829-CrossCheck.jpg
Scientific Editor Work List	11829-Scientific editor work list.pdf